help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on July 20, 2006, doi:10.1164/rccm.200601-048OC

Am. J. Respir. Crit. Care Med., Volume 174, Number 7, October 2006, 743-752

A more recent version of this article appeared on October 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200601-048OCv1
174/7/743    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Abraham, W. M
Right arrow Articles by Sackner, M. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abraham, W. M
Right arrow Articles by Sackner, M. A

Submitted on January 12, 2006
Accepted on July 14, 2006

Whole Body Periodic Acceleration Modifies Experimental Asthma in Sheep

William M Abraham1*, Ashfaq Ahmed1, Irakli Serebriakov1, Isabel T Lauredo1, Jorge Bassuk2, Jose A Adams2, and Marvin A Sackner1

1 Division of Pulmonary Disease and Critical Care Medicine, University of Miami at Mount Sinai Medical Center, Miami Beach, Florida, USA, 2 Department of Neonatology, Mount Sinai Medical Center, Miami Beach, Florida, USA

* To whom correspondence should be addressed. E-mail: abraham{at}msmc.com.

Rationale: Nitric oxide is released from vascular endothelium in response to increased pulsatile shear stress. Nitric oxide inhibits mast cell activation, is anti-inflammatory and so might be protective in asthma. Objectives: We determined if a non-invasive, motion platform that imparts periodic sinusoidal inertial forces to the whole body along the spinal axis (pGz) causing release of endothelial nitric oxide, modulates experimental asthma in sheep. Methods: Allergic sheep were either untreated (control), treated with pGz alone or after receiving intravenously, the nitric oxide synthase inhibitor, Nw -Nitro-L-arginine methyl ester (L-NAME), before aerosol challenge with Ascaris suum and the effect on antigen-induced airway responses determined. Bronchoalveolar lavage cells obtained 6 hours after antigen challenge were analyzed for nuclear factor-kappa beta activity in the respective groups. Results: One-hour pGz treatment prior to antigen challenge, reduced the early airway response and blocked the late airway response, but did not prevent the antigen-induced airway hyperresponsiveness 24 hours after challenge. Administration of L-NAME before pGz completely reversed this protection, whereas L-NAME alone did not affect the antigen-induced responses. Nuclear factor-kappa beta activity was 1.9- and 1.8- fold higher in the control and L-NAME+pGz groups, respectively, compared to pGz treated animals. Extending the pGz treatment to twice daily for 3 days and then 1 hour before antigen challenge blocked the early and late airway responses, the 24-hour airway hyperresponsiveness and airway inflammatory cell response. Conclusion: Whole body pGz modulates allergen-induced airway responses in allergic sheep


Key words: Nitric oxide, non-invasive periodic acceleration, asthma therapy, animal models




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
W. C. Moore and S. P. Peters
Update in Asthma 2006
Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 649 - 654.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2006 American Thoracic Society
  Solid Organ Transplant for the Intensivist 2008